Related Experiment Video
Updated: Mar 10, 2026

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
Preload time-dependent effects of Panax ginseng on postprandial glucose tolerance. A randomized controlled study in
1Department of Process and Life Science Engineering, Division Food and Pharma, Lund University, Lund, Sweden.
Objectives:
Panax ginseng (P. ginseng, C.A. Meyer) is suggested to improve blood glucose regulation, but evidence remains inconsistent. We examined whether consuming P. ginseng as a preload before a carbohydrate-rich meal modulates postprandial glucose and insulin responses.
Methods:
In a randomized, double-blind, crossover trial, 22 healthy middle-aged adults consumed P. ginseng tablets containing 32 mg total ginsenosides (primarily Rg1, Re, Rf, Rb1, Rc, Rb2, and Rd) or an identical placebo without ginsenosides at three time points prior to a standardized breakfast: 90 min, 45 min, and immediately before meal initiation.
Results:
Compared with placebo, P. ginseng ingested 90 min prior to the meal reduced 0-150 min postprandial blood glucose incremental areas under the curves (iAUC) by 29% (P < 0.001) and maximum individual glucose peaks (iPeak) by 26% (P < 0.001). When P. ginseng was ingested 45 min prior to the meal, postprandial iPeaks were reduced by 15% (P < 0.01). Postprandial insulin iAUCs decreased by 24% (P < 0.001) and 23% (P < 0.01) when ginseng was consumed 90 and 45 min, respectively, before the meal. Similarly, compared with placebo, the insulin iPeaks were significantly lower after ginseng intake at 90 or 45 min prior to the meal (-23%, P < 0.001 and -15%, P < 0.01, respectively). No effects on blood glucose or insulin responses were observed when ginseng was taken immediately before the meal (P > 0.05).
Conclusion:
Preload timing is critical for optimizing ginseng's glucoregulatory effects, supporting its potential role in dietary strategies for glycemic management.Trial registered at ClinicalTrials.gov (NCT02392819). URL:clinicaltrials.gov/study/NCT02392819.
More Related Videos
06:13Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
Related Concept Videos
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Oral Hypoglycemic Agents: Glinides
Hypoglycemia and Glucagon
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Dipeptidyl Peptidase 4 Inhibitors